Companies › NBP
NOVABRIDGE BIOSCIENCES (NBP)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001778016 · EDGAR filings · Updated 2026-07-24
NOVABRIDGE BIOSCIENCES (NBP) has reported institutional ownership of 11.0%, with 48 institutional managers holding positions valued at $72.1M per the latest 13F reporting period.
Filings this week (1)
- 2026-07-24 — Foreign issuer report (6-K) filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-17 — Foreign issuer report (6-K) filed
- 2026-07-10 — Insider transaction reported (Form 4)
- 2026-07-10 — Insider transaction reported (Form 4)
- 2026-07-08 — Insider transaction reported (Form 4)
- 2026-07-08 — Initial insider ownership filed (Form 3)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, NOVABRIDGE BIOSCIENCES has 48 institutional holders and institutional ownership of 11.0%.
Insider activity
Insiders reported 0 transactions (0 buys, 0 sells) across 7 reporting insiders, with a net reported value of $0.
Related companies
PROKIDNEY CORP (PROK) · AN2 Therapeutics Inc (ANTX) · SANUWAVE HEALTH INC (SNWV) · CARIBOU BIOSCIENCES INC (CRBU) · SNDL INC (SNDL) · IMMUNIC (IMUX)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-24.